SILO PHARMA, INC. Payments for Repurchase of Other Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- SILO PHARMA, INC. payments for repurchase of other equity for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- SILO PHARMA, INC. payments for repurchase of other equity for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- SILO PHARMA, INC. payments for repurchase of other equity for the quarter ending 2024-06-30 was $57.66K.
- SILO PHARMA, INC. payments for repurchase of other equity for the quarter ending 2024-03-31 was $115.45K.
- SILO PHARMA, INC. payments for repurchase of other equity for fiscal 2023 was $471.12K.
| Period end | Payments for Repurchase of Other Equity 3 month | Payments for Repurchase of Other Equity 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $173.11K POS AM · filed 2026-04-14 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $367.54K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $57.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $513.27K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $115.45K 10-Q · filed 2025-05-09 | |
| 2023-12-31 | $194.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $471.12K 10-K · filed 2025-03-28 |
| 2023-09-30 | $145.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |